Home › High Blood Pressure › New York › Rochester
High Blood Pressure clinical trials in Rochester, NY
3 studies for High Blood Pressure are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Rochester Clinical Research, Inc, Rochester
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
- Rochester Clinical Research, LLC, Rochester
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
RecruitingPhase 2
- Vanda Investigative Site, Rochester
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL21 studies
- Boston, MA21 studies
- Dallas, TX16 studies
- Nashville, TN13 studies
- Birmingham, AL11 studies
- Houston, TX11 studies
- Durham, NC10 studies
- Atlanta, GA10 studies
- Tucson, AZ10 studies
- New York City, NY9 studies
- Miami, FL9 studies
- Baltimore, MD9 studies
Other studies in Rochester
- Acute Myeloid Leukemia16 studies
- Lung Cancer15 studies
- Breast Cancer15 studies
- Cancer (all types)14 studies
- Obesity14 studies
- Overweight13 studies
- Non-Small Cell Lung Cancer13 studies
- Prostate Cancer10 studies
- Metastatic Cancer8 studies
- Multiple Myeloma8 studies
- Bladder Cancer7 studies
- Myotonic Dystrophy7 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.